In Vitro Antibiotic Susceptibility of Initial Pseudomonas aeruginosa Isolates From United States Cystic Fibrosis Patients

被引：6

作者：

VanDevanter, Donald R. ^{[1
]}

Van Dalfsen, Jill M. ^{[2
]}

Burns, Jane L. ^{[3
,4
]}

Mayer-Hamblett, Nicole ^{[4
,5
]}

机构：

[1] Case Western Reserve Univ, Sch Med, Pediat, Cleveland, OH 44106 USA

[2] Univ Washington, Seattle Childrens Res Inst, Seattle, WA 98195 USA

[3] Univ Washington, Seattle Childrens Hosp, Infect Dis, Seattle, WA 98195 USA

[4] Univ Washington, Pediat, Seattle, WA 98195 USA

[5] Seattle Childrens Res Inst, Biomed Stat, Seattle, WA 98101 USA

来源：

JOURNAL OF THE PEDIATRIC INFECTIOUS DISEASES SOCIETY | 2015年 / 4卷 / 02期

关键词：

cystic fibrosis; initial P aeruginosa; susceptibility;

D O I：

10.1093/jpids/pit052

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

Chronic antibiotic suppression of cystic fibrosis (CF) infections has increased in the United States, as has isolation of Pseudomonas aeruginosa with reduced antibiotic susceptibility. However, analysis of the susceptibilities of 193 initial P aeruginosa clinical isolates suggests that antibiotic susceptibilities are comparable with wild-type strains despite expanded antipseudomonal treatment in the CF community.

引用

页码：151 / 154

页数：4

共 50 条

[21] EVALUATION OF BIOFILM PRODUCTION BY PSEUDOMONAS AERUGINOSA ISOLATES RECOVERED FROM CYSTIC FIBROSIS AND NON-CYSTIC FIBROSIS PATIENTS
Perez, L. R. R.
Costa, M. C. N.
Freitas, A. L. P.
Barth, A. L.
BRAZILIAN JOURNAL OF MICROBIOLOGY, 2011, 42 (02) : 476 - 479
[22] Pyoverdine-Dependent Virulence of Pseudomonas aeruginosa Isolates From Cystic Fibrosis Patients
Kang, Donghoon
Revtovich, Alexey, V
Chen, Qingquan
Shah, Kush N.
Cannon, Carolyn L.
Kirienko, Natalia, V
FRONTIERS IN MICROBIOLOGY, 2019, 10
[23] Genetic relatedness and host specificity of Pseudomonas aeruginosa isolates from cystic fibrosis and non-cystic fibrosis patients
AbdulWahab, Atqah
Taj-Aldeen, Saad J.
Ibrahim, Emad
Abdulla, Shaikha H.
Muhammed, Ramees
Ahmed, Irshad
Abdeen, Yasmine
Sadek, Omnia
Abu-Madi, Marawan
INFECTION AND DRUG RESISTANCE, 2014, 7 : 309 - 316
[24] Evaluation of the E test for the assessment of synergy of antibiotic combinations against multiresistant Pseudomonas aeruginosa isolates from cystic fibrosis patients
B. Balke
M. Hogardt
S. Schmoldt
L. Hoy
H. Weissbrodt
S. Häussler
European Journal of Clinical Microbiology and Infectious Diseases, 2006, 25 : 25 - 30
[25] Influence of biofilm formation in the susceptibility of Pseudomonas aeruginosa from Brazilian patients with cystic fibrosis
Ferreira, Alex Guerra
Leao, Robson Souza
D'Alincourt Carvalho-Assef, Ana Paula
Folescu, Tania Wrobel
Barth, Afonso Luis
Marques, Elizabeth Andrade
APMIS, 2010, 118 (08) : 606 - 612
[26] Antibiotic therapy against Pseudomonas aeruginosa in cystic fibrosis
Taccetti, G.
Campana, S.
Neri, A. S.
Boni, V.
Festini, F.
JOURNAL OF CHEMOTHERAPY, 2008, 20 (02) : 166 - 169
[27] Systematic Review and Meta-Analysis on the Prevalence and Antibiotic Susceptibility Pattern in Pseudomonas aeruginosa Isolated from Cystic Fibrosis Patients
Rastegar-Kashkouli, Ali
Khaledi, Azad
Moammer, Farzaneh
Sanani, Mohammad Ghenaatpisheh
Heidari, Mohammad Mahdi
Eghbal, Aynaz Foroughi
EURASIAN JOURNAL OF MEDICINE, 2024, 56 (03) : 189 - 198
[28] PREVALENCE AND PERSISTENCE OF POLYAGGLUTINABLE PSEUDOMONAS-AERUGINOSA IN ISOLATES FROM CYSTIC-FIBROSIS PATIENTS
OJENIYI, B
HOIBY, N
ROSDAHL, VT
APMIS, 1991, 99 (02) : 187 - 195
[29] Evaluation of in vitro activity of ceftolozane-tazobactam compared to other antimicrobial agents against Pseudomonas aeruginosa isolates from cystic fibrosis patients
Gherardi, Giovanni
Linardos, Giulia
Pompilio, Arianna
Fiscarelli, Ersilia
Di Bonaventura, Giovanni
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2019, 94 (03) : 297 - 303
[30] In vitro activity of cefiderocol against Pseudomonas aeruginosa isolated from cystic fibrosis patients
Monogue, Marguerite L.
Desai, Dhara
Pybus, Christine A.
Sanders, James M.
Clark, Andrew E.
Greenberg, David E.
MICROBIOLOGY SPECTRUM, 2023, 11 (06):

← 1 2 3 4 5 →